The Reply - 12/10/14
Doi : 10.1016/j.amjmed.2014.06.018
Torben Bjerregaard Larsen, MD, PhD a, b, Lars Hvilsted Rasmussen, MD, PhD b, Anders Gorst-Rasmussen, MSc, PhD a, b, Flemming Skjøth, MSc, PhD a, b, Mary Rosenzweig, MSc c, Deirdre A. Lane, PhD b, d, Gregory Y.H. Lip, MD b, d
a Department of Cardiology, Aalborg AF Study Group, Aalborg University Hospital, Denmark
b Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Faculty of Health, Aalborg University, Denmark
c Division of Pharmacovigilance and Medical Devices, Danish Health and Medicines Authority, Copenhagen, Denmark
d Centre for Cardiovascular Sciences, University of Birmingham City Hospital, UK
El texto completo de este artículo está disponible en PDF.
| Funding: See original article for this information. |
|
| Conflicts of Interest: See original article for this information. |
|
| Authorship: All authors had access to the data and a role in writing the manuscript. |
© 2014
Elsevier Inc. Reservados todos los derechos.
Vol 127 - N° 10
P. e21 - octobre 2014 Regresar al número
Artículo precedente
- Myocardial Ischemic Events in ‘Real World’ Patients Treated with Dabigatran
- Rahman Shah
- Acupuncture is More Than Placebo Treatment
- Mary van den Berg-Wolf
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.
¿Ya suscrito a @@106933@@ revista ?